URINARY TRACT INFECTION IN THE POPULATION OF ANDIJAN REGION, UZBEKISTAN: CLINICAL FEATURES AND TREATMENT APPROACHES
Main Article Content
Abstract
Urinary tract infection (UTI) is one of the most frequently encountered infectious diseases in primary health care practice and represents a significant public health concern worldwide. The prevalence of UTIs is influenced by multiple factors, including demographic characteristics, climatic conditions, hygienic practices, socio-economic status, comorbidities, and access to medical care. Women are particularly at higher risk due to anatomical and physiological predisposition.
The aim of this study was to evaluate the clinical features, prevalence, etiological factors, and treatment approaches of urinary tract infections among the population of the Andijan region of Uzbekistan, with a focus on primary health care settings.
A cross-sectional clinical-epidemiological study was conducted among adult patients attending primary health care centers. The study included clinical examination, laboratory urinalysis, ultrasound imaging of the urinary system, and bacteriological analysis of urine samples to identify causative pathogens and assess antimicrobial sensitivity patterns.
The results demonstrated that urinary tract infections were detected in 12.4% of examined individuals, with a significantly higher prevalence among female patients. The most common causative microorganism was Escherichia coli, followed by other Gram-negative uropathogens. Risk factors included poor personal hygiene, previous history of UTIs, urinary stasis, comorbid chronic diseases, and delayed healthcare seeking behavior.
Therapeutic management included antibacterial therapy based on sensitivity testing, combined with phytotherapeutic agents as adjunct treatment. This combined approach demonstrated improved clinical outcomes, faster symptom resolution, and reduced recurrence rates compared to monotherapy in selected cases.
The findings highlight that early diagnosis and appropriate management of UTIs at the primary care level are essential for preventing complications such as pyelonephritis, chronic kidney damage, and recurrent infections.
Article Details
References
Hooton TM, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection. Clinical Infectious Diseases. 2010;50(5):625–663.
Stamm WE. Scientific and clinical challenges in the management of urinary tract infections. American Journal of Medicine. 2002;113(Suppl 1A):1S–4S.
Kahlmeter G. The ECO.SENS project: antimicrobial resistance in urinary pathogens. International Journal of Antimicrobial Agents. 2003;22(Suppl 2):49–52.
Yamamoto S, et al. Molecular epidemiology of uropathogenic Escherichia coli. Journal of Infectious Diseases. 1997;175(5):1195–1202.
Sobel JD, Kaye D. Urinary tract infections. In: Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 9th ed. 2020.
Rubin RH, Shapiro ED, Andriole VT, Davis RJ, Stamm WE. Evaluation of new anti-infective drugs for UTI. Clinical Infectious Diseases. 1992;15(Suppl 1):S216–S227.
Warren JW. Catheter-associated urinary tract infections. Infectious Disease Clinics of North America. 1997;11(3):609–622.